Knock-down of ubiquitin-specific protease 22 by micro-RNA interference inhibits colorectal cancer growth

Hui Xu1, Yan-Long Liu, Yan-Mei Yang

  • 1Department of Oncosurgery, The Affiliated 4th Hospital of Harbin Medical University, 37 Yiyuan Street, Nangang District, Harbin, 150001, People's Republic of China.

Abstract

Insights

Targeting ubiquitin-specific protease 22 (USP22) may inhibit colorectal cancer growth. Suppressing USP22 with micro-interfering RNA (miRNA) reduced cell proliferation and tumor growth in mice, suggesting USP22 as a potential cancer therapy target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Ubiquitin-specific protease 22 (USP22) is implicated in epithelial malignancies and solid tumors.
  • USP22 functions as a cancer stem cell marker, indicating its potential as a therapeutic target.
  • Understanding USP22's role in colorectal cancer is crucial for developing novel treatment strategies.

Purpose of the Study:

  • To investigate the functional role of USP22 in the human colorectal cancer cell line HCT116.
  • To suppress USP22 expression using micro-interfering RNA (miRNA) and assess its effects on cancer progression.
  • To evaluate USP22 as a potential therapeutic target for colorectal cancer.

Main Methods:

  • USP22 expression was suppressed in HCT116 cells using miRNA.
  • Cellular proliferation, cell cycle, and apoptosis were analyzed post-USP22 knockdown.
  • A tumor xenograft model in nude mice was utilized to assess the in vivo effects of USP22 inhibition.
  • Immunohistochemical staining was performed to evaluate USP22 expression in tumor tissues.

Main Results:

  • USP22 knockdown significantly inhibited cellular proliferation and induced G1 phase cell cycle arrest.
  • Apoptosis was reduced, and Major Vault Protein (MVP) expression was downregulated following USP22 suppression.
  • In vivo studies demonstrated suppressed tumor growth in mice treated with USP22 miRNA silencing vector.
  • Immunohistochemistry confirmed decreased USP22 expression in tumors after miRNA intervention.

Conclusions:

  • USP22 plays a critical role in colorectal tumor formation and growth, partly through regulating cell proliferation via a USP22-dependent pathway.
  • USP22 acts as a transcriptional factor regulating the drug-resistant gene MVP.
  • Targeting USP22 presents a promising therapeutic strategy for colorectal cancer and potentially other malignancies.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K